130 related articles for article (PubMed ID: 12670479)
1. PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation.
Hong G; Davis B; Khatoon N; Baker SF; Brown J
Biochem Biophys Res Commun; 2003 Apr; 303(3):782-7. PubMed ID: 12670479
[TBL] [Abstract][Full Text] [Related]
2. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.
Goetze S; Bungenstock A; Czupalla C; Eilers F; Stawowy P; Kintscher U; Spencer-Hänsch C; Graf K; Nürnberg B; Law RE; Fleck E; Gräfe M
Hypertension; 2002 Nov; 40(5):748-54. PubMed ID: 12411472
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
[TBL] [Abstract][Full Text] [Related]
4. Activation of PPARgamma increases PTEN expression in pancreatic cancer cells.
Farrow B; Evers BM
Biochem Biophys Res Commun; 2003 Jan; 301(1):50-3. PubMed ID: 12535639
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2003 Mar; 302(2):415-20. PubMed ID: 12604364
[TBL] [Abstract][Full Text] [Related]
6. PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM
Gastroenterology; 2002 Oct; 123(4):1163-78. PubMed ID: 12360479
[TBL] [Abstract][Full Text] [Related]
7. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
Kintscher U; Goetze S; Wakino S; Kim S; Nagpal S; Chandraratna RA; Graf K; Fleck E; Hsueh WA; Law RE
Eur J Pharmacol; 2000 Aug; 401(3):259-70. PubMed ID: 10936484
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
[TBL] [Abstract][Full Text] [Related]
10. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.
Jiang G; Dallas-Yang Q; Li Z; Szalkowski D; Liu F; Shen X; Wu M; Zhou G; Doebber T; Berger J; Moller DE; Zhang BB
Diabetes; 2002 Aug; 51(8):2412-9. PubMed ID: 12145152
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.
Patel L; Pass I; Coxon P; Downes CP; Smith SA; Macphee CH
Curr Biol; 2001 May; 11(10):764-8. PubMed ID: 11378386
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
14. How can anti-diabetics suppress tumours?
Wood I
Trends Pharmacol Sci; 2001 Aug; 22(8):399. PubMed ID: 11478985
[No Abstract] [Full Text] [Related]
15. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.
Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR
Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK
J Clin Invest; 2000 Aug; 106(4):523-31. PubMed ID: 10953027
[TBL] [Abstract][Full Text] [Related]
18. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
19. Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice.
Shen Q; Cline GW; Shulman GI; Leibowitz MD; Davies PJ
J Biol Chem; 2004 May; 279(19):19721-31. PubMed ID: 14998989
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Singh Ahuja H; Liu S; Crombie DL; Boehm M; Leibowitz MD; Heyman RA; Depre C; Nagy L; Tontonoz P; Davies PJ
Mol Pharmacol; 2001 Apr; 59(4):765-73. PubMed ID: 11259621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]